Y Combinator and Ginkgo Bioworks have unveiled a partnership meant to give synthetic biology startups access to tools in exchange for equity.
Erin Brodwin 👩🚀Scoop: @ycombinator + its first bio startup, the $1.4 billion organism company @Ginkgo, unveiled a new partnership today. Startups get access to Ginkgo's cell-building tools; Ginkgo gets equity.
The frontrunners are making beef-like burgers with ingredients from plants. Next come the startups who aim to make real meat from animal cells.
Erin Brodwin 👩🚀With so many(!) alt-meat companies at this year's #goodfoodconference, I took a minute to profile the ones leading the charge
- 4 make plant-based burgers like @BeyondMeat🌱
- 7 aim to make real, cell-based meat using animal cells 🥩
The marijuana breathalyzer could help distinguish between people who've used cannabis legally in the past and people who are currently high.
Erin Brodwin 👩🚀Hound Labs, a startup that aims to make the first marijuana breathalyzer, raised a fresh $30 million on Tuesday. They also put out the first study offering a glimpse of how the handheld device works.
'Law & Order' creator Dick Wolf is an investor.
uBiome had a plan to go from citizen science project to serious health company. But research underlying its products was flawed from the start.
Erin Brodwin 👩🚀I was working on this piece for @businessinsider before I left to get married. Yesterday, we published it. uBiome ran clinical tests using scientific data that was flawed, insiders say. Now, uBiome + the journal that pubbed the research are investigating.
Erin Brodwin 👩🚀Scoop: uBiome’s foundational science—the peer-reviewed paper behind its clinical and consumer tests—contained data from infants and pets.
Erin Brodwin 👩🚀But the problems went deeper than that, insiders said: uBiome's basic science was flawed.
Medicare coverage for Myriad's GeneSight test, which aims to help people pick treatments for depression, could be at risk.
Erin Brodwin 👩🚀My colleague @emmarcourt has a great story today on a test that claims to tell you how well you'll respond to depression meds. Scientists are increasingly questioning the utility of tests like these.